ANEB
Anebulo Pharmaceuticals (ANEB)
$42
About Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.90
52 Week Low
$0.00
Market cap
13.1M
Dividend yield
-
Volume
--
Avg. volume
407
P/E ratio
-1.65
Anebulo Pharmaceuticals News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.90
52 Week Low
$0.00
Market cap
13.1M
Dividend yield
-
Volume
--
Avg. volume
407
P/E ratio
-1.65